Invenomic Capital Management’s Olin OLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-387,259
Closed -$8.07M – 174
2025
Q4
$8.07M Buy
387,259
+156,714
+68% +$3.38M 0.38% 87
2025
Q3
$5.76M Buy
+230,545
New +$5.12M 0.28% 98

Other funds holding OLN

Invenomic Capital Management's OLN Position: Q1 2026 in Review

Invenomic Capital Management sold out of Olin (OLN) in Q1 2026, closing a stake of 387,259 shares — an estimated $8.07M sold.

Invenomic Capital Management first reported a position in OLN in Q3 2025 and held it in 2 quarters. The position peaked at $8.07M in Q4 2025. 422 funds tracked by Wall St. Rank hold OLN as of Q1 2026.

  • Invenomic Capital Management reported no remaining Olin position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 387,259 Olin shares in Q1 2026, an estimated $8.07M.
  • Invenomic Capital Management first reported a position in Olin in Q3 2025 and held it in 2 quarters.
  • Invenomic Capital Management's Olin position peaked at $8.07M in Q4 2025.
  • 422 funds tracked by Wall St. Rank held Olin as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.